How to Read a Liver Panel And Build a Differential Diagnosis From It

Why It Matters

Accurate interpretation of liver chemistries directs timely investigation of chronic toxins or disease, preventing progression to liver failure and guiding appropriate treatment.

Key Takeaways

• Distinguish hepatocellular vs cholestatic labs to guide diagnosis.
• ALT > AST suggests liver origin; AST > ALT hints extra‑hepatic sources.
• Elevated alkaline phosphatase plus GGT points to biliary obstruction.
• Persistent mixed enzyme elevation warrants investigation of chronic toxins or disease.
• Albumin and INR assess liver synthetic function and acute failure risk.

Summary

The video walks clinicians through a systematic read‑out of a standard liver panel, emphasizing how to separate hepatocellular injury markers (ALT, AST) from cholestatic indicators (alkaline phosphatase, bilirubin) and synthetic function tests (albumin, INR). By framing each group of labs as a distinct physiological pathway, the presenter equips physicians to pinpoint where the liver problem originates.

Key points include the relative weight of ALT versus AST—ALT predominates in pure liver injury, while a higher AST may signal muscle breakdown or alcohol use. Alkaline phosphatase rises with bile‑flow obstruction, but because it is also produced by bone and placenta, a concurrent GGT elevation helps confirm a biliary source. The discussion also notes that bilirubin can increase from hemolysis, underscoring the need to correlate lab patterns with clinical context.

The speaker illustrates the approach with a case of a healthy 39‑year‑old who returned from Asia with mixed enzyme elevations: ALT 96 U/L, AST 49 U/L, alkaline phosphatase 128 U/L, and a prior GGT rise. He stresses that a five‑month, progressively worsening pattern points away from an acute viral hepatitis and toward chronic low‑level toxin exposure—such as herbal supplements, alcohol, or fatty liver disease—while still keeping autoimmune or chronic infection on the differential.

For clinicians, mastering this algorithm shortens the diagnostic odyssey, prioritizes targeted testing (e.g., GGT, viral serologies, autoantibodies), and flags patients at risk for acute liver failure via declining albumin or rising INR. Ultimately, a nuanced liver panel interpretation translates into earlier intervention and better outcomes.

Original Description

Your doctor ordered a liver panel. Now you're staring at ALT, AST, GGT, ALP, bilirubin, albumin — and have no idea what any of it means or why it's flagged. More importantly: what is your doctor actually thinking when they see these numbers?

In this segment, Dr. Austin Baraki — a practicing clinician — gives a complete plain-language breakdown of every marker on a standard liver panel and then builds a live differential diagnosis from a real patient presentation. This is clinical reasoning in real time.

Part 1 — Reading the Liver Panel:

• Hepatocellular tests (ALT and AST): what liver cell injury looks like on paper, the troponin/creatine kinase analogy, and why AST is found in both liver and skeletal muscle

• The ALT vs. AST ratio: when ALT is higher than AST, the results point to the liver, and when it should make a clinician look elsewhere

• Cholestatic tests (alkaline phosphatase and bilirubin): how bile flow problems show up, the difference between intrahepatic and extrahepatic obstruction, and why alk phos isn't always a liver marker

• Synthetic function tests (albumin and INR): how doctors assess whether the liver is still doing its job — and why a rising INR is a red flag for acute liver failure

• GGT: what it is, why it's not part of the standard panel, and how clinicians use it to differentiate liver from bone

Part 2 — Building the Differential:

• Why a 'mixed pattern' — hepatocellular and cholestatic abnormalities together — is clinically common and what it means

• Why the chronicity and trajectory of abnormalities matter more than a single snapshot value

• The top differential for a fit, young, asymptomatic patient with 5 months of progressive liver enzyme elevation: toxic exposure (drugs, supplements, alcohol), fatty liver disease, chronic infection, and autoimmune liver disease

• Why Dr. Baraki keeps probing about supplements — the 'Chinese herbal tea remembered on day 5' story

• Why exercise, protein, and creatine are explicitly NOT on this differential — and what would have to be true for exercise to even be considered

This is Part 3 of 5 in the Barbell Medicine Mystery Case series. Full episode linked below.

Timestamps:

0:00 Introduction: Three Questions for Dr. Baraki

0:20 Initial Read: Young, Healthy Patient, Mixed Lab Abnormalities

0:45 The Liver Panel Explainer: Hepatocellular Tests

1:14 CK/Troponin Analogy — Why Cell Injury Tests Work the Same Way

1:43 ALT and AST Are Also Found in Muscle

2:06 Rhabdomyolysis and Elevated AST — How Doctors Get Tricked

2:53 The ALT vs. AST Ratio: Reading the Pattern

3:13 Cholestatic Tests: Alkaline Phosphatase and Bilirubin

4:22 Alkaline Phosphatase Beyond the Liver: Bone, Placenta, Prostate

5:07 Synthetic Function Tests: Albumin and INR

6:04 How to Identify the Predominant Pattern in Mixed Abnormalities

7:01 GGT: What It Is and How Clinicians Actually Use It

7:20 GGT to Differentiate Liver vs. Bone in Elevated Alk Phos

8:24 Building the Differential: 5 Months of Progressive Elevation

9:48 Chronicity and Trajectory Matter More Than a Single Value

10:38 The Ongoing Toxic Exposure Question — Why He Keeps Asking

11:20 Alcohol and Fatty Liver: The Most Common Causes

11:48 Viral Infections and Autoimmune Disease: Bottom of the List

12:23 Dr. Baraki's Final Summary Before Moving Forward

Full Barbell Medicine Mystery Case episode: https://youtu.be/qRSJ33V1GIk?si=89Cojal_o5vNEwm9

Next Steps:

For evidence-based resistance training programs: barbellmedicine.com/training-programs

For individualized training consultation: barbellmedicine.com/coaching

Explore our full library of articles on health and performance: barbellmedicine.com/resources

To join Barbell Medicine Plus and get ad-free listening, product discounts, exclusive content, and more: https://barbellmedicine.supercast.com/

To consult with Drs. Baraki or Feigenbaum email us at [e-mail]